XML 70 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
12 Months Ended
Dec. 28, 2013
Income Taxes [Abstract]  
Income Taxes
5.Income Taxes

The components of income from continuing operations before provision for income taxes are as follows:

(In thousands)
 
2013
  
2012
  
2011
 
Domestic
 
$
8,913
  
$
11,445
  
$
9,823
 
Foreign
  
24,113
   
24,485
   
28,320
 
 
 
$
33,026
  
$
35,930
  
$
38,143
 


The components of the provision for income taxes from continuing operations are as follows:

(In thousands)
 
2013
  
2012
  
2011
 
Current Provision:
 
  
  
 
  Federal
 
$
1,986
  
$
1,798
  
$
123
 
  Foreign
  
7,955
   
7,363
   
5,575
 
  State
  
436
   
559
   
473
 
 
  
10,377
   
9,720
   
6,171
 
 
            
Deferred (Benefit) Provision:
            
  Federal
  
1,325
   
(3,980
)
  
(317
)
  Foreign
  
(2,354
)
  
(782
)
  
(1,309
)
  State
  
(32
)
  
(106
)
  
(260
)
 
  
(1,061
)
  
(4,868
)
  
(1,886
)
 
 
$
9,316
  
$
4,852
  
$
4,285
 

The provision for income taxes included in the accompanying statement of income is as follows:

(In thousands)
 
2013
  
2012
  
2011
 
Continuing Operations
 
$
9,316
  
$
4,852
  
$
4,285
 
Discontinued Operation
  
(34
)
  
451
   
(1,511
)
 
 
$
9,282
  
$
5,303
  
$
2,774
 

The Company receives a tax deduction upon the exercise of nonqualified stock options and the vesting of restricted stock units. The current provision for income taxes in the consolidated statement of income does not reflect $351,000, $132,000, and $371,000 of such excess tax benefits in 2013, 2012, and 2011, respectively, from the exercise of stock options and vesting of restricted stock units.
The provision for income taxes from continuing operations in the accompanying statement of income differs from the provision calculated by applying the statutory federal income tax rate of 35% to income from continuing operations before provision for income taxes due to the following:

(In thousands)
 
2013
  
2012
  
2011
 
Provision for Income Taxes at Statutory Rate
 
$
11,559
  
$
12,576
  
$
13,350
 
Increases (Decreases) Resulting From:
            
  State income taxes, net of federal tax
  
304
   
295
   
(140
)
  U.S. tax (benefit) cost of foreign earnings
  
(119
)
  
791
   
(53
)
  Foreign tax rate differential
  
(2,681
)
  
(2,298
)
  
(3,094
)
  Provision (reversal) of tax benefit reserves, net
  
853
   
624
   
(1,596
)
  Change in valuation allowance
  
(968
)
  
(7,051
)
  
(4,183
)
  Nondeductible expenses
  
1,580
   
775
   
746
 
  Research and development tax credits
  
(638
)
  
(623
)
  
(324
)
  Other
  
(574
)
  
(237
)
  
(421
)
 
 
$
9,316
  
$
4,852
  
$
4,285
 

Net deferred tax (liability) asset in the accompanying consolidated balance sheet consists of the following:

(In thousands)
 
2013
  
2012
 
Deferred Tax Asset:
 
  
 
  Foreign and alternative minimum tax credit carryforwards
 
$
3,819
  
$
5,659
 
  Reserves and accruals
  
5,125
   
6,493
 
  Net operating loss carryforwards
  
16,452
   
15,147
 
  Inventory basis difference
  
2,797
   
2,468
 
  Research and development
  
1,017
   
1,193
 
  Employee compensation
  
3,199
   
2,229
 
  Allowance for doubtful accounts
  
595
   
486
 
  Revenue recognition
  
253
   
286
 
  Other
  
209
   
88
 
    Deferred Tax Asset, Gross
  
33,466
   
34,049
 
    Less: Valuation Allowance
  
(13,905
)
  
(14,315
)
    Deferred Tax Asset, Net
  
19,561
   
19,734
 
Deferred Tax Liability:
        
  Goodwill and intangible assets
  
(20,923
)
  
(15,393
)
  Fixed asset basis difference
  
(3,619
)
  
(2,974
)
  Reserves and accruals
  
(207
)
  
(342
)
  Other
  
(65
)
  
(107
)
    Deferred Tax Liability
  
(24,814
)
  
(18,816
)
    Net Deferred Tax (Liability) Asset
 
$
(5,253
)
 
$
918
 

The deferred tax assets and liabilities are presented in the accompanying balance sheet within other current assets, other assets, other current liabilities and long-term deferred income taxes based on when the tax benefits are expected to be realized and on a net basis by tax jurisdiction.
The Company has established valuation allowances related to certain domestic and foreign deferred tax assets on deductible temporary differences, tax losses, and tax credit carryforwards. The valuation allowance at year-end 2013 was $13,905,000, consisting of $950,000 in the U.S. and $12,955,000 in foreign jurisdictions. The decrease in the valuation allowance in 2013 of $410,000 related primarily to the release of valuation allowances in the U.S. and several foreign jurisdictions due to an increase in current year income and expected future income. Compliance with ASC 740 requires the Company to periodically evaluate the necessity of establishing or adjusting a valuation allowance for deferred tax assets depending on whether it is more likely than not that a related tax benefit will be realized in future periods. When assessing the need for a valuation allowance in a tax jurisdiction, the Company evaluates the weight of all available evidence to determine whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. As part of this evaluation, the Company considers its cumulative three-year history of earnings before income taxes, taxable income in prior carryback years, future reversals of existing taxable temporary differences, prudent and feasible tax planning strategies, and expected future results of operations. As of year-end 2013, the Company continued to maintain a valuation allowance in the U.S. against its state operating loss carryforwards due to the uncertainty of future profitability in state jurisdictions. As of year-end 2013, the Company maintained valuation allowances in certain foreign jurisdictions because of the uncertainty of future profitability.
At year-end 2013, the Company had domestic state and foreign net operating loss carryforwards of $28,963,000 and $59,708,000, respectively, U.S. foreign tax credit carryforwards of $2,182,000, U.S. research and development tax credits of $467,000, and U.S. alternative minimum tax credits of $1,154,000. The domestic state loss carryforwards will expire in the years 2014 through 2032. Their utilization is limited to future taxable income from the Company's domestic subsidiaries. Of the foreign net operating loss carryforwards, $11,790,000 will expire in the years 2014 through 2032, and the remainder do not expire. The U.S. foreign tax credits will expire in the years 2018 through 2019. The research and development tax credits will expire in the years 2030 through 2033 and the alternative minimum tax credits may be carried forward indefinitely.
The Company has not recognized a deferred tax liability for the difference between the book basis and the tax basis of its investment in the stock of its domestic subsidiaries, related primarily to unremitted earnings of subsidiaries, because it does not expect this basis difference to become subject to tax at the parent level. The Company believes it can implement certain tax strategies to recover its investment in its domestic subsidiaries tax-free. It is the Company's intention to reinvest indefinitely the earnings of its international subsidiaries in order to support the current and future capital needs of their operations in the foreign jurisdictions. Through year-end 2013, the Company has not provided for U.S. income taxes on approximately $145,926,000 of unremitted foreign earnings. The U.S. tax cost has not been determined due to the fact that it is not practicable to estimate at this time. The related foreign tax withholding, which would be required if the Company were to remit these foreign earnings to the U.S., would be approximately $2,000,000.
The Company operates within multiple tax jurisdictions and could be subject to audit in those jurisdictions. Such audits can involve complex income tax issues, which may require an extended period of time to resolve and may cover multiple years. In management's opinion, adequate provisions for income taxes have been made for all years subject to audit.
As of year-end 2013, the Company had $5,423,000 of unrecognized tax benefits which, if recognized, would reduce the effective tax rate. A tabular reconciliation of the beginning and ending amount of unrecognized tax benefits at year-end 2013 and 2012 is as follows:

(In thousands)
 
2013
  
2012
 
Unrecognized tax benefits, beginning of year
 
$
4,194
  
$
3,308
 
Gross increases—tax positions in prior periods
  
449
   
185
 
Gross decreases—tax positions in prior periods
  
-
   
(41
)
Gross increases—current-period tax positions
  
1,086
   
1,231
 
Settlements
  
(6
)
  
(182
)
Lapses of statutes of limitations
  
(158
)
  
(367
)
Currency translation
  
(142
)
  
60
 
Unrecognized tax benefits, end of year
 
$
5,423
  
$
4,194
 

The Company recognizes accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. The Company has accrued $1,776,000 and $1,196,000 for the potential payment of interest and penalties at year-end 2013 and 2012, respectively. The interest and penalties included in the consolidated statement of income was an expense (benefit) of $205,000 and $(6,000) in 2013 and 2012, respectively.
The Company is currently under audit in certain non-U.S. taxing jurisdictions. It is reasonably possible that over the next fiscal year the amount of liability for unrecognized tax benefits may be reduced by up to $842,000 due to the re-evaluation of current uncertain tax positions as a result of examinations or from the expiration of tax statutes of limitations.
The Company remains subject to U.S. Federal income tax examinations for the tax years 2010 through 2013, and to non-U.S. income tax examinations for the tax years 2006 through 2013. In addition, the Company remains subject to state and local income tax examinations in the U.S. for the tax years 2002 through 2013.